Company Intelligence
Freenome
Freenome provides enterprise-grade artificial intelligence solutions, delivering specialized Freenome Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- South San Francisco, United States
- Website
- www.freenome.com
- Founded
- 2014
- Status
- Active
- Products
- 2
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Freenome is a Healthcare AI company based in South San Francisco, United States, founded in 2014.
South San Francisco biotechnology company developing multiomics blood tests for early cancer detection.
Verified founder profile on Brel: Riley Ennis.
What it does
Through the deployment of Freenome Platform, Freenome provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
Freenome Platform
Why It Matters
Freenome provides enterprise-grade artificial intelligence solutions, delivering specialized Freenome Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
SimpleScreen CRC
Explore SimpleScreen CRC by Freenome. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and…
View product intelligence -
Freenome — Biotechnology
Explore Freenome — Biotechnology by Freenome. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Freenome
Industry
Industries served
- Biotechnology
Products
Technologies
Capabilities
Freenome's platform applies AI and deep learning across multiomic feature sets trained on large clinical datasets, including real-world training data Freenome highlights…
Features
- AI/ML-enabled multiomics blood tests for colorectal, lung, and broader multi-cancer early detection, including SimpleScre
- SimpleScreen CRC
- pipeline programs built on real-world training data
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
- December 5, 2025: Freenome announced business combination agreement with Perceptive Capital Solutions Corp. Latest
- Company founded 2014 · founded Source
- Product 2014 · product Source
- Leadership 2025 · leadership Source
- Development 2025 · development Source
- Its colorectal cancer program includes SimpleScreen CRC, which Freenome has positioned following pivotal PREEMPT CRC study results and journal publication. Research
- The company emphasizes diagnostic yield and performance in average-risk populations — a design choice reflected in PREEMPT CRC enrollment and subsequent JAMA publication cited by Elliott in official statements. Research
Frequently Asked Questions
What does Freenome do?
Freenome specializes in artificial intelligence, developing Freenome Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Freenome based and when was it founded?
Freenome is based in United States and was founded in 2014.
What are the main products offered by Freenome?
The flagship platform from Freenome is Freenome Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Freenome?
Freenome primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.